ENvue Medical Inc. (FEED : NASDAQ)
Common Stock
$0.43
USD
+0.14 (50.84%)
Last updated: 2026-10-07
Follow FEED
FEED
ENvue Medical Inc.
WealthAwesomePerformance
1 Day
+50.84%
1 Week
+39.94%
1 Month
-89.33%
YTD
-95.07%
Key Statistics
Market Cap
$369,486
52W High
$84.79
52W Low
$0.20
P/E Ratio
-
50 Day MA
$3.24
200 Day MA
$15.08
Beta
1.45
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/7/2026 | $0.30 | $0.43 | $0.26 | $0.43 | $0.43 | 13,796 |
| 10/6/2026 | $0.25 | $0.28 | $0.25 | $0.28 | $0.28 | 2,475 |
| 10/5/2026 | $0.20 | $0.24 | $0.20 | $0.24 | $0.24 | 3,853 |
| 10/2/2026 | $0.45 | $0.45 | $0.23 | $0.44 | $0.44 | 5,300 |
| 10/1/2026 | $0.28 | $0.28 | $0.28 | $0.28 | $0.28 | 100 |
| 9/30/2026 | $0.36 | $0.40 | $0.27 | $0.31 | $0.31 | 4,809 |
| 9/29/2026 | $0.43 | $0.55 | $0.30 | $0.38 | $0.38 | 7,256 |
| 9/28/2026 | $0.41 | $0.55 | $0.38 | $0.43 | $0.43 | 11,685 |
| 9/25/2026 | $0.65 | $0.65 | $0.41 | $0.41 | $0.41 | 10,600 |
| 9/24/2026 | $0.50 | $0.63 | $0.40 | $0.49 | $0.49 | 10,671 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on FEED's historical volatility
30-Day Vol
451.4%
Annualized
90-Day Vol
293.2%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$0.36
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$0.41 | US$0.09 – US$1.92 |
| 60 trading days | US$0.38 | US$0.04 – US$3.45 |
| 90 trading days | US$0.36 | US$0.02 – US$5.34 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About ENvue Medical Inc.
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers UroShield Ultra, which is designed to prevent bacterial colonization and biofilm formation in urinary catheters; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures. In addition, it provides PainShield MD, a single patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; PainShield Plus, a dual patch-based therapeutic ultrasound technology; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and internationally. ENvue Medical, Inc. was formerly known as NanoVibronix, Inc. and changed its name to ENvue Medical, Inc. in December 2025. The company was incorporated in 2003 and is based in Tyler, Texas.
Financials
- Revenue (TTM)
- $1.93M
- EBITDA
- $-14.14M
- Profit Margin
- 0.00%
- ROE (TTM)
- -59.14%
- EPS (Diluted)
- -339.36
- Book Value
- 45.04
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About FEED.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| GLE | Global Engine Group Holding Limited Ordinary Shares | $4.00 | +877.02% |
| SXTC | China SXT Pharmaceuticals Inc | $2.83 | +126.40% |
| PFAI | Pinnacle Food Group Limited Class A Common Shares | $5.07 | +116.67% |
| CHARR | Charlton Aria Acquisition Corporation Rights | $0.18 | +80.00% |
| SBFM | Sunshine Biopharma Inc | $0.70 | +75.92% |
| BIYA | Baiya International Group Inc. Ordinary Shares | $2.30 | +68.50% |
| QETAR | Quetta Acquisition Corporation Right | $0.72 | +47.94% |
| NCPL | Netcapital Inc | $1.59 | +45.87% |